| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $17.9M | -44.3% | -62.4% |
| SG&A Expense | $10.3M | -22.9% | -27.6% |
| Operating Income | -$28.3M | +38.0% | +54.4% |
| Income Tax | $0 | — | — |
| Net Income | -$26.3M | +39.3% | +54.5% |
| EPS (Basic) | -$0.43 | +39.4% | +54.7% |
| EPS (Diluted) | -$0.43 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $93.7M | +8.0% | +17.7% |
| Short-term Investments | $148.1M | -15.9% | -54.4% |
| Current Assets | $245.6M | -8.2% | -40.1% |
| Total Assets | $276.6M | -7.7% | -37.9% |
| Current Liabilities | $17.6M | -14.4% | -55.9% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$110.5M | — | — |
| Capital Expenditures | $374K | — | — |
| Investing Cash Flow | $132.5M | — | — |
| Financing Cash Flow | $570K | — | — |
| Free Cash Flow | -$110.9M | — | — |
| +54.7% |
| $30.4M |
| +0.3% |
| +1.0% |
| Total Liabilities | $76.3M | -4.3% | -23.6% |
| Stockholders' Equity | $200.3M | -9.0% | -42.1% |